Ground Swell Capital’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Ground Swell Capital’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$27K	Buy	+858	New	+$23.2K	0.05%	413

Other funds holding SGNT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Ground Swell Capital's SGNT Position: Q3 2014 in Review

Ground Swell Capital opened a new position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2014: 858 shares worth $27K. The stake represents 0.05% of the portfolio and ranks #413 among its holdings.

114 funds tracked by Wall St. Rank hold SGNT as of Q3 2014.

Ground Swell Capital held 858 shares of SAGENT PHARMACEUTICALS INC COM STK (DE) worth $27K as of Q3 2014.
SAGENT PHARMACEUTICALS INC COM STK (DE) was a new Ground Swell Capital position in Q3 2014.
SAGENT PHARMACEUTICALS INC COM STK (DE) made up 0.05% of Ground Swell Capital's portfolio in Q3 2014, its #413 holding.
114 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.